We provide you with 20 years of free, institutional-grade data for SNDX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SNDX. Explore the full financial landscape of SNDX stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-04 | 1395937 | SNDX | 10-Q | Url |
| 2025-05-05 | 1395937 | SNDX | 10-Q | Url |
| 2025-03-03 | 1395937 | SNDX | 10-K | Url |
| 2024-11-05 | 1395937 | SNDX | 10-Q | Url |
| 2024-08-01 | 1395937 | SNDX | 10-Q | Url |
| 2024-05-08 | 1395937 | SNDX | 10-Q | Url |
| 2024-02-27 | 1395937 | SNDX | 10-K | Url |
| 2023-11-02 | 1395937 | SNDX | 10-Q | Url |
| 2023-08-03 | 1395937 | SNDX | 10-Q | Url |
| 2023-05-08 | 1395937 | SNDX | 10-Q | Url |
| 2023-02-28 | 1395937 | SNDX | 10-K | Url |
| 2022-11-03 | 1395937 | SNDX | 10-Q | Url |
| 2022-08-08 | 1395937 | SNDX | 10-Q | Url |
| 2022-05-09 | 1395937 | SNDX | 10-Q | Url |
| 2022-03-01 | 1395937 | SNDX | 10-K | Url |
| 2021-11-15 | 1395937 | SNDX | 10-Q | Url |
| 2021-08-09 | 1395937 | SNDX | 10-Q | Url |
| 2021-05-11 | 1395937 | SNDX | 10-Q | Url |
| 2021-03-12 | 1395937 | SNDX | 10-K | Url |
| 2020-11-05 | 1395937 | SNDX | 10-Q | Url |
| 2020-08-06 | 1395937 | SNDX | 10-Q | Url |
| 2020-05-07 | 1395937 | SNDX | 10-Q | Url |
| 2020-03-05 | 1395937 | SNDX | 10-K | Url |
| 2019-11-07 | 1395937 | SNDX | 10-Q | Url |
| 2019-08-07 | 1395937 | SNDX | 10-Q | Url |
| 2019-05-08 | 1395937 | SNDX | 10-Q | Url |
| 2019-03-07 | 1395937 | SNDX | 10-K | Url |
| 2018-11-05 | 1395937 | SNDX | 10-Q | Url |
| 2018-08-08 | 1395937 | SNDX | 10-Q | Url |
| 2018-05-09 | 1395937 | SNDX | 10-Q | Url |
| 2018-03-08 | 1395937 | SNDX | 10-K | Url |
| 2017-11-08 | 1395937 | SNDX | 10-Q | Url |
| 2017-08-10 | 1395937 | SNDX | 10-Q | Url |
| 2017-05-09 | 1395937 | SNDX | 10-Q | Url |
| 2017-03-14 | 1395937 | SNDX | 10-K | Url |
| 2016-11-14 | 1395937 | SNDX | 10-Q | Url |
| 2016-08-15 | 1395937 | SNDX | 10-Q | Url |
| 2016-05-16 | 1395937 | SNDX | 10-Q | Url |
| 2016-01-04 | 1395937 | SNDX | S-1 | Url |
| 2014-03-27 | 1395937 | SNDX | S-1 | Url |
Syndax Pharmaceuticals, Inc(NASDAQ:SNDX) 
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treat...
Website: http://www.syndax.com
Founded: 2005
Full Time Employees: 35
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about SNDX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.